EICHORCondition: Obesity · Overweight · Sponsor: Novo Nordisk A/S
This study will look at how much cagrilintide helps people with overweight or obesity lower their body weight. Cagrilintide is a new investigational medicine. Doctors may not yet prescribe cagrilintide. Participants will either get cagrilintide or placebo. Which treatment participants get is decided by chance. Participants are two times more likely to get cagrilintide than placebo. Like all medicines, the study medicine may have side effects. Possible side effects will be followed carefully during the study. For each participant, the study will last for about 1 year and 6 months.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Diablo Clinical Research, Inc. | Walnut Creek, California, United States | — |
| Univ of Colorado at Denver | Aurora, Colorado, United States | — |
| Florida Inst For Clin Res LLC | Orlando, Florida, United States | — |
| Oviedo Medical Research, LLC | Oviedo, Florida, United States | — |
| Walgreens - Store 11760 | Oak Park, Illinois, United States | — |
| Midwest Inst For Clin Res | Indianapolis, Indiana, United States | — |
| StudyMetrix Research LLC | City of Saint Peters, Missouri, United States | — |
| PharmQuest Life Sciences LLC | Greensboro, North Carolina, United States | — |
| Selma Medical Associates | Winchester, Virginia, United States | — |
| CIPREC Pueyrredon | Buenos Aires, Argentina | — |
| CEDIC Centro de Investigación Clínica | CABA, Argentina | — |
| Sydney Cardiometabolic Centre | Liverpool, New South Wales, Australia | — |
+ 28 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07220642